Transmission of Cytomegalovirus ( CMV ) from CMV‐Seropositive Organ Donors to CMV‐Seronegative Pediatric Solid Organ Transplant ( SOT ) Recipients
Pediatric Transplantation · 2026-04 · 30 (4)
DOI: 10.1111/petr.70316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 09.04.2026. Verfasst von Geraldine Huynh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Organ Transplantation, Tissue Donors. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Blood Services, University of Alberta Department of Pediatrics, Women and Children's Health Research Institute,.
Abstract (Originalsprache)
Background
The risk factors for donor‐acquired (DA) CMV transmission in CMV‐seronegative pediatric solid organ transplant (SOT) recipients (R‐) receiving organs from CMV‐seropositive donors (D+) remain unknown in the era of routine antiviral prophylaxis.
Methods
DA‐CMV transmission was defined as CMV antigenemia/DNAemia and/or seroconversion in a D+/R‐ recipient by 13 months post‐transplant. DA‐CMV transmission, along with donor and recipient demographics, was studied in a retrospective cohort of CMV D+/R‐ children who had a SOT at the Stollery Children's Hospital from 2000 to 2018. All patients were expected to receive at least 3 months of CMV‐active antiviral prophylaxis.
Results
105 CMV D+/R‐ pediatric SOT recipients (48 liver, 35 heart, 4 lung, 18 kidney) were analyzed; DA‐CMV transmission occurred in 58 patients (55%). Frequency of DA‐CMV transmission was highest in lung (75%), followed by liver (69%), then kidney (61%), and was lowest in heart recipients (31%). Median time to DA‐CMV transmission was 4.8 months (3.4–6.7). In a multivariable cox regression model including organ, donor and recipient age and sex, risk of DA‐CMV transmission was significantly lower in heart versus liver recipients (HR 0.30, 95% CI 0.14, 0.65, p = 0.003).
Conclusion
Understanding factors that result in non‐transmission of CMV to seronegative recipients despite receiving a seropositive organ may guide more targeted use of antiviral prophylaxis in pediatric SOT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
- Women and Children's Health Research Institute, Edmonton, Alberta, Canada.
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Geraldine Huynh, Curtis Mabilangan, Maryna Yaskina, Jutta Preiksaitis, Catherine Burton
Förderung
- Canadian Blood Services
- University of Alberta Department of Pediatrics
- Women and Children's Health Research Institute,
- Women and Children's Health Research Institute
Zitieren
APA
Huynh, G., Mabilangan, C., Yaskina, M., Preiksaitis, J., & Burton, C. (2026). Transmission of Cytomegalovirus ( CMV ) from CMV‐Seropositive Organ Donors to CMV‐Seronegative Pediatric Solid Organ Transplant ( SOT ) Recipients. Pediatric Transplantation, 30(4). https://doi.org/10.1111/petr.70316
Vancouver
Huynh G, Mabilangan C, Yaskina M, Preiksaitis J, Burton C. Transmission of Cytomegalovirus ( CMV ) from CMV‐Seropositive Organ Donors to CMV‐Seronegative Pediatric Solid Organ Transplant ( SOT ) Recipients. Pediatric Transplantation. 2026;30(4). doi:10.1111/petr.70316
BibTeX
@article{Huynh2026,
author = {Huynh, Geraldine and Mabilangan, Curtis and Yaskina, Maryna and Preiksaitis, Jutta and Burton, Catherine},
title = {Transmission of Cytomegalovirus ( CMV ) from CMV‐Seropositive Organ Donors to CMV‐Seronegative Pediatric Solid Organ Transplant ( SOT ) Recipients},
journal = {Pediatric Transplantation},
year = {2026},
volume = {30},
number = {4},
doi = {10.1111/petr.70316}
}
EUVIMED